Drug development is the way to bring a new drug to market when the lead compound has been recognized through drug discovery. This includes preclinical research in microorganisms and organisms, applying for regulatory status for example, through the U.S. Food and Drug Administration for an investigative new drug to start human clinical trials and possibly incorporate regulatory approval processes with a quiet new application for drug advertising.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
